SLC16A1 and cancer: Because the metabolic reprogramming in cancer cells may also result in the overexpression of MCT1/MCT4 in many cancers [4,7], MCT-targeting PET studies provide an opportunity to achieve more accurate and useful understanding of certain aspects of the tumor-specific metabolism [8,16].